Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301
Stock Information for Aridis Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.